Trials / Completed
CompletedNCT02287610
A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis
A Non-Interventional Study to Evaluate the Effectiveness of Delayed-Release Prednisone (RAYOS) on Clinical Assessments and Serologic Disease Activity in Patients With Active Rheumatoid Arthritis in the Clinical Practice Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall objective of the study is to assess the effectiveness of switching from immediate-release prednisone (conventional) therapy to delayed-release prednisone (RAYOS) in patients with moderately to severely active Rheumatoid Arthritis (RA), managed according to standard of care in clinical practice settings.
Detailed description
Adult Rheumatoid Arthritis (RA) participants previously receiving immediate release prednisone were enrolled in the trial if they and their physicians both consented. Once entered, participant baseline data were captured and they were switched to delayed-release prednisone and followed for approximately 12 weeks. Study with completed results acquired from Horizon in 2024.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RAYOS (delayed-release prednisone) | Physicians may prescribe any dosage of RAYOS based on what is appropriate for the treatment of the patient's condition as determined by performing standard of care assessments. |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2014-11-10
- Last updated
- 2024-12-18
- Results posted
- 2017-02-03
Source: ClinicalTrials.gov record NCT02287610. Inclusion in this directory is not an endorsement.